Johnson & Johnson said it’s delaying the rollout of its Covid-19 vaccine in Europe after U.S. regulators paused immunizations with the shot pending a review of rare blood clots.
Read More
Johnson & Johnson said it’s delaying the rollout of its Covid-19 vaccine in Europe after U.S. regulators paused immunizations with the shot pending a review of rare blood clots.
Read More
Tags:
Categories:
Comments are closed